How Ph.D. was paid
$9.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Terry Rosen, Ph.D.Chief Executive Officer and Director | $775,000 | — | $2,199,450 | $6,008,860 | $658,750 | $14,753 | $9,656,813 |
| Robert C. Goeltz, IIChief Financial Officer | $540,000 | — | $493,210 | $1,386,660 | $243,000 | $9,694 | $2,672,564 |
| Juan Carlos Jaen, Ph.D.President | $660,000 | — | $666,500 | $1,848,880 | $330,000 | $15,544 | $3,520,924 |
| Jennifer JarrettChief Operating Officer | $660,000 | — | $666,500 | $1,848,880 | $330,000 | $10,819 | $3,516,199 |
| Richard Markus, M.D., Ph.D.Chief Medical Officer | $552,307 | $100,000 | $936,153 | $2,636,263 | $270,000 | $11,576 | $4,506,299 |
What changed and why
- $9.7MCEO total compensation increased to $9,656,813 in 2025 from $7,279,504 in 2024.
- Dr. Rosen received no cash bonus for 2025 performance.
- Stock and option awards formed the majority of the CEO's total compensation package.
- 94%Approximately 94% of votes cast supported the 2024 say-on-pay proposal.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.